NAMI Pharma Marketing Blog Grassley
View PDF of blog article here
Similar Posts
Culling the $$$ Evidence: National Alliance for Mental Illness
Grassley’s team has asked NAMI to disclose the specifics of its funding so that people with mental illness and their families, as well as the public and healthcare officials, can see for themselves how conflicted this advocacy group is.
Congress & the White House must remedy a prescription for danger – LA Times / CBS News
Congress & the White House must remedy a prescription for danger – LA Times / CBS News Thu, 1 Apr 2004 For those who missed the CBS evening News broadcast (Tues March 30) about FDA’s suppression of evidence, a video of that powerful report can be viewed online. http://www.cbsnews.com/stories/2004/03/30/eveningnews/main609491.shtml CBS…
At FDA, Changes In Name Only–Agency Puts Business interests Above Safety
At FDA, Changes In Name Only–Agency Puts Business interests Above Safety Fri, 30 Sep 2005 The sudden resignation of FDA Commissioner, Lester Crawford, after just two months in office, has prompted a bipartisan Senate investigation and requests both by the Senate committee HELP and by congressman Maurice Hinchey (NY) and…
Antibiotic Ketek Trial in Children
One day following a rport in The New York Times, Sanifo-Aventis, manufacturer of Ketek, suspended the trial in children. The FDA has not announced any action.
Sec Defense Rumsfeld Tamiflu Holdings
Fortune Magazine confirms our report (October) that "The prospect of a bird flu outbreak may be panicking people around the globe, but it’s proving to be very good news for Defense Secretary."
FDA Says Bayer Failed to Reveal Lethal Drug Risks–but Fails to Change Licensure or Label_NYT
FDA issued an advisory stating that the concealed study results demonstrate "that use of Trasylol may increase the chance for death, serious kidney damage, congestive heart failure and strokes."